ArticlePharmaceutics2024

Quality-by-Design-Driven Nanostructured Lipid Scaffold of Apixaban: Optimization, Characterization, and Pharmacokinetic Evaluation.

Kiran Patil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.